Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In late 2012, over 80 speakers and delegates from around the world came together in Oxford for two days of intensive talks and debate around the subject of Big Data. Speaker and conference videos, and the complete conference report are now available on the Big Data Conference website (http://bigdata.medsci.ox.ac.uk/).

The Conference highlighted the tremendous opportunities presented by very large data sets and the exciting new tools that are becoming available to scrutinise them with more depth and precision. However, there are also considerable challenges that need to be addressed such as data quality, privacy and security, public engagement and the ethics of data sharing.

The Conference was held in collaboration with Stanford University and Stanford organised a follow up meeting in May 2013. It is the intention that this becomes an annual event. 

Links:

Big Data Conference website

Big Data in Biomedicine (Follow up meeting at Stanford University) 

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.